Publicaciones en colaboración con investigadores/as de IRB Barcelona - Institute for Research in Biomedicine (13)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2021

  1. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis

    Gastroenterology, Vol. 160, Núm. 5, pp. 1725-1740.e2

2020

  1. A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia

    Blood Cancer Journal, Vol. 10, Núm. 1

  2. Polymorphic Inversions Underlie the Shared Genetic Susceptibility of Obesity-Related Diseases

    American Journal of Human Genetics, Vol. 106, Núm. 6, pp. 846-858

2019

  1. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

    Neurotherapeutics, Vol. 16, Núm. 3, pp. 808-827

2018

  1. Cancertool: A visualization and representation interface to exploit cancer datasets

    Cancer Research, Vol. 78, Núm. 21, pp. 6320-6328

2017

  1. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

    Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12

2016

  1. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis

    Gut, Vol. 66, Núm. 12, pp. 2069-2079

  2. Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis

    Mucosal Immunology, Vol. 9, Núm. 4, pp. 950-959

2014

  1. Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine

    PLoS ONE, Vol. 9, Núm. 3

2012

  1. The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles

    Journal of Biological Chemistry, Vol. 287, Núm. 21, pp. 17789-17800

2011

  1. Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

    European Heart Journal, Vol. 32, Núm. 2, pp. 177-183